Parametric Portfolio Associates’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-27,975
Closed -$69K 3727
2021
Q4
$69K Sell
27,975
-128
-0.5% -$300 ﹤0.01% 3586
2021
Q3
$71K Buy
28,103
+4,874
+21% +$12.5K ﹤0.01% 3558
2021
Q2
$66K Buy
23,229
+1,165
+5% +$3.01K ﹤0.01% 3519
2021
Q1
$52K Buy
+22,064
New +$53K ﹤0.01% 4021
2019
Q1
Sell
-16,696
Closed -$15K 3950
2018
Q4
$15K Sell
16,696
-21,567
-56% -$33K ﹤0.01% 3890
2018
Q3
$79K Sell
38,263
-4,481
-10% -$9.41K ﹤0.01% 3872
2018
Q2
$77K Buy
42,744
+1,499
+4% +$3.02K ﹤0.01% 3826
2018
Q1
$97K Buy
41,245
+25,106
+156% +$58.9K ﹤0.01% 3862
2017
Q4
$30K Buy
16,139
+1,464
+10% +$3.2K ﹤0.01% 3886
2017
Q3
$36K Buy
14,675
+1,102
+8% +$2.73K ﹤0.01% 4001
2017
Q2
$37K Buy
+13,573
New +$37.9K ﹤0.01% 3973

Other funds holding LCTX